Table 3.
Outcomea | Final PACT score |
P-value | |||
---|---|---|---|---|---|
Poor (score 0–1, N = 21) | Acceptable (score 2, N = 87) | Good (score 3, N = 177) | Excellent (score 4, N = 119) | ||
Overall survival at 1-yeara | 57 [34–75] | 60 [49–69] | 59 [52–66] | 67 [58–75] | 0.11 |
Non-relapse mortality at 1-yearb | 33 [14–54] | 24 [16–34] | 27 [21–34] | 16 [10–23] | 0.03 |
Relapse at 1-yearb | 24 [8–44] | 30 [21–40] | 24 [18–31] | 25 [18–33] | 0.90 |
Grade II-IV acute GVHD at 100 daysb | 48 [25–67] | 32 [23–42] | 44 [38–45] | 34 [26–43] | 0.72 |
Chronic GVHD at 1 yearb | 38 [17–59] | 37 [27–47] | 30 [23–37] | 38 [29–46] | 0.76 |
Duration of index hospitalizationc | 35 [29–42] | 29 [25–40] | 30 [24–39] | 29 [23–38] | 0.17 |
Days alive and out of hospital in the first 100-daysc | 58 [45–70] | 65 [44–78] | 66 [45–77] | 70 [54–79] | 0.07 |
[ ] indicates range
GVHD Graft-versus-host disease
Kaplan–Meier estimate with 95% confidence intervals
Cumulative incidence estimate with 95% confidence intervals
Median with inter-quartile range